What are the treatment options for gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Gout

The management of gout requires a three-pronged approach: treatment of acute flares with oral colchicine, NSAIDs, or glucocorticoids; urate-lowering therapy with medications like allopurinol; and lifestyle modifications to reduce risk factors. 1

Treatment of Acute Gout Flares

First-line Options

  • Oral colchicine: Most effective when started within 12 hours of symptom onset

    • Recommended dosing: 1.2 mg initially, followed by 0.6 mg one hour later 1
    • For patients with renal impairment:
      • Mild to moderate impairment: No dose adjustment required but monitor closely
      • Severe impairment: Treatment course should not be repeated more than once every two weeks 2
      • Dialysis patients: Reduced to a single dose of 0.6 mg 2
  • NSAIDs:

    • Short-acting NSAIDs like naproxen 500 mg twice daily for 5 days are preferred in elderly patients 1
    • Avoid in patients with eGFR < 30 ml/min or history of peptic ulcer disease/GI bleeding 1
  • Corticosteroids:

    • Oral prednisone 30-35 mg daily for 3-5 days 1
    • Particularly recommended for elderly patients due to favorable safety profile 1
    • Intra-articular injections effective for 1-2 large joints 1

Adjunctive Therapy

  • Topical ice application 1
  • For severe polyarticular involvement, consider combination therapy (e.g., NSAIDs + colchicine) 1

Urate-Lowering Therapy (ULT)

Indications for ULT

  • Recurrent gout attacks (≥2 per year)
  • Presence of tophi
  • Joint damage
  • Chronic kidney disease 1

Medication Options

  1. Allopurinol (first-line):

    • Starting dose: 100 mg daily (lower in renal insufficiency)
    • Increase by 100 mg weekly
    • Target serum uric acid level: < 6 mg/dL
    • Typical maintenance dose: 200-600 mg/day depending on severity 1
  2. Febuxostat:

    • Alternative first-line if allopurinol is not tolerated or contraindicated 1
  3. Probenecid:

    • First choice among uricosurics
    • Can be combined with xanthine oxidase inhibitors for refractory cases 1

Prophylaxis During ULT Initiation

  • Colchicine 0.5-1.0 mg daily for first 6 months of ULT to prevent paradoxical flares 1
  • Alternative options: low-dose NSAIDs or corticosteroids 3

Lifestyle Modifications

  • Weight loss for overweight/obese patients 1
  • Dietary modifications:
    • Restrict purine-rich foods (organ meats, shellfish)
    • Avoid alcohol, especially beer
    • Avoid beverages sweetened with high-fructose corn syrup
    • Increase consumption of low-fat dairy products 1, 3
  • Hydration: At least 2 liters daily 1
  • Regular moderate physical activity 1

Special Considerations

Renal Impairment

  • Assess renal function before initiating therapy 1
  • Avoid NSAIDs and colchicine if eGFR < 30 ml/min 1
  • For allopurinol in severe renal failure: Start at 0.3 mg/day with careful monitoring 2

Hepatic Impairment

  • For mild to moderate impairment: No dose adjustment required for acute treatment, but monitor closely
  • For severe impairment: Treatment course should not be repeated more than once every two weeks 2

Pregnancy

  • Oral, intramuscular, or intra-articular glucocorticoids are recommended for acute attacks 1
  • Options include prednisone 30-35 mg daily for 3-5 days or intra-articular injections 1

Common Pitfalls to Avoid

  1. Medication interactions: Strong CYP3A4 inhibitors (clarithromycin, ketoconazole) require colchicine dose reductions to prevent toxicity 1

  2. Missing early signs of colchicine toxicity: Monitor for gastrointestinal symptoms 1

  3. Inadequate monitoring: Regular serum uric acid level checks are necessary to ensure target levels are maintained 1

  4. Insufficient duration of ULT: Treatment should continue for at least 3 months after uric acid levels fall below target in those without tophi, and 6 months in those with tophi 3

  5. Failure to provide prophylaxis when initiating ULT, which can trigger acute flares 1, 3

References

Guideline

Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis, treatment, and prevention of gout.

American family physician, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.